# 2026-08-12 AFTERNOON autonomous decision — Agentic account ••••1041

Scan timestamp: approximately 17:32–17:37 UTC / 13:32–13:37 ET
Policy: `playbook/autonomous-policy.md` (ACTIVE)
Decision: **NO TRADE — hold five positions; review/place/cancel nothing.**

## Live broker state

- Authorized account 433711041 verified active cash Individual, nickname Agentic, `agentic_allowed=true`; no other account traded.
- Decision snapshot: total value $331.8361657363; equities $325.6261657363; cash/buying power $6.21; unsettled funds $0; no non-equity exposure.
- Final verification: total value $331.875965715; equities $325.665965715; cash/buying power $6.21.
- Positions, all fully sellable and intraday quantity zero: AVGO 0.095750 @ $411.28; MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; SHOP 0.862075 @ $144.09; NESR 0.736516 @ $33.74.
- Open-ish orders checked independently at decision and final verification: new=0, queued=0, confirmed=0, unconfirmed=0, partially_filled=0. All orders created since 2026-08-12=0; therefore no fills today and pending commitment $0.
- Liquid buying power after pending orders: $6.21. Policy 80% deployable=$4.968; reserve=$1.242. No purchase was forced because five holdings already occupy the book, available dollars are operationally tiny, and no confirmed replacement setup materially exceeded the weakest valid holding.
- Final equity deployment 98.13% and cash 1.87% of account value. The 80/20 requirement applies to currently available liquid buying power, not a forced portfolio rebalance.

## Kill switches / risk

- Below-$10 switch clear.
- Versus opening $334.4932 reference, afternoon value was down about 0.79%; versus recent $337.2507 reference, drawdown about 1.60%: 5% daily and 10% recent-high pauses clear.
- Aggregate entry-to-binding-invalidation risk remains approximately $5.329, below the default ~$6 target. Risk by holding: AVGO $0.123; MA $2.552; BAC $0.753; SHOP $0.509; NESR $1.392.
- Broker/tool/risk state verified. No stop widened; no averaging down.
- Clean-entry/rotation gate active: no confirmed policy-labeled replacement justified turnover.

## Regime and current context

- Live tape: SPY $772.78 (+0.29%), QQQ $725.08 (+0.92%), IWM $302.27 (+0.43%). XLK $189.24 (+1.69%) led; XLF -0.06%, XLE -0.04%, and XLY -1.06% lagged.
- Broad daily scan classified bullish breadth / mixed rotation: SPY near highs, IWM breakout leadership, and financial/industrial/healthcare intermediate leadership; technology constructive but selective.
- July CPI was reported as tame by current market coverage and supported risk appetite. AI/cloud earnings boosted CRWV, SMCI, and NBIS, but their afternoon gaps remained too extended for a disciplined swing entry. Macro event risk continues with PPI on 2026-08-13.

## Holdings — ranked action

1. **BAC — HOLD, 15/16.** Mark about $64.62; day +0.96%; unrealized about +$2.61. Above SMA20 $62.15/SMA50 $58.90; 20/60-day momentum +5.6%/+28.4%; Q2 EPS/revenue supportive. Binding invalidation $61.40; targets $64.80/$66. Near target/resistance: evaluate acceptance or stall, no chase/add.
2. **MA — HOLD / weakest operational watch, 10–14/16 depending entry-confirmation weighting.** Mark $558.11; day -0.59%; unrealized -$1.63. Near SMA20 $556.12 and above SMA50 $524.21; 20/60-day momentum +4.4%/+14.6%; high-quality earnings/margins. Binding invalidation $550; targets $583/$600. Exit/rotation review if $550 decisively breaks; never average down.
3. **SHOP — HOLD / protect winner, 12/16.** Mark $149.04; day -2.34%; unrealized +$4.27. Extended above SMA20 $129.05/SMA50 $120.73 with +21.4%/+56.7% momentum and strong Q2 growth, but XLY lagged and valuation/volatility are elevated. Binding invalidation $143.50; targets $160/$166. No add.
4. **AVGO — HOLD, 11/16.** Mark $418.74; day +0.64%; unrealized +$0.71. Above SMA20 $395.12/SMA50 $394.34; 20-day +6.9%, 60-day -5.4%; AI revenue/margin trend supports thesis. Binding invalidation $410; targets $440/$455. No add while entry is not a retest.
5. **NESR — HOLD / profit-protection watch, 10/16.** Mark $35.47; day -1.50%; unrealized +$1.27. Very extended above SMA20 $28.47/SMA50 $27.18; 20/60-day +22.9%/+38.6%; earnings beat supports catalyst, but XLE was flat and gap risk remains. Binding invalidation $31.85; targets $36.60/$38. No add; reassess if target stalls or momentum fails.

No holding breached binding invalidation, no score was clearly below 10, and no target showed a confirmed stall warranting a tiny fractional exit.

## Fresh candidates

1. **JPM — 13/16 WATCH.** $364.98, fresh high; SMA20 $351.62/SMA50 $335.52; 20/60-day +5.6%/+20.7%; Q2 EPS $6.14 vs $5.59 estimate. Preferred pullback/retest $355–360, stop $345, targets $385/$395 (~2R). No entry: extended and duplicates BAC financial exposure.
2. **AMZN — 13/16 WATCH.** Around $268.75; SMA20 $254.37/SMA50 $247.62; 20/60-day +10.0%/+1.9%; strong latest revenue/EPS. Preferred $258–263 support retest, stop $247, targets $287/$300 (~2R). No confirmed retest and would add consumer/SHOP correlation.
3. **GE — 13/16 WATCH.** Around $366.96; SMA20 $358.93/SMA50 $353.68; 20/60-day +4.1%/+26.2%; industrial leadership and Q2 beat. Entry $358–365 after stabilization, stop $348, targets $389/$405 (~2R). No free slot or confirmed superior replacement.
4. **NVDA — 12–13/16 WATCH.** $223.97 (+2.98%); SMA20 $207.80/SMA50 $206.27; 20-day +2.7%, 60-day -7.7%; strong revenue/margins, earnings due Aug. 26. Entry only $215–220 retest or confirmed >$225 breakout-retest; stop $205; targets $236.50/$250. No chase and correlation with AVGO.
5. **V — 12/16 WATCH.** Around $358.74; below SMA20 $362.36 but above SMA50 $345.74; high-quality margins and Q3 beat. Require stabilization $352–359, stop $342, targets $374/$390. Trend repair incomplete.
6. **CRWV/SMCI/NBIS — 10–12/16 post-earnings WATCH only.** Afternoon moves roughly +19%, +18%, and +28%; direct catalysts but one-day gaps, high volatility and weaker intermediate trend/quality. Require multi-session base or retest; no chase.

## Action / exact result

- Order reviews: 0.
- Orders placed: 0.
- Orders canceled: 0.
- Fills: 0.
- Position changes: 0.
- Deployed cash this run: $0. Remaining buying power: $6.21; designated 20% liquid reserve: $1.242; undeployed qualifying portion: $4.968 due to no confirmed setup/slot.

## Limitations

Daily indicators use completed bars through Aug. 11; current volume was partial. Some MCP financial records lacked cash-flow/balance-sheet detail, and NESR/NBIS quarterly financial statements were unavailable. R:R scenarios can be exceeded by gap/slippage. No guaranteed-return claim is made.
